Cargando…

Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer

Background: Immune cell death (ICD) is a type of tumor cell death that has recently been shown to activate and regulate tumor immunity. However, the role of ICD-related long non-coding RNAs (lncRNAs) in gastric cancer remains to be clarified. Methods: We obtained 375 tumor samples from the Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zeyu, Su, Duntao, Thakur, Abhimanyu, Zhang, Kui, Xia, Fada, Yan, Yuanliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110873/ https://www.ncbi.nlm.nih.gov/pubmed/37081965 http://dx.doi.org/10.3389/fphar.2023.1162995

Ejemplares similares

A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer
por: Su, Duntao, et al.
Publicado: (2022)

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer
por: Su, Duntao, et al.
Publicado: (2023)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

The safety, benefits and future development of overnight and outpatient thyroidectomy
por: Su, Duntao, et al.
Publicado: (2023)

Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response
por: Zhang, Kui, et al.
Publicado: (2023)

Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer
por: Song, Xuesong, et al.
Publicado: (2022)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
por: Zhang, Zeyu, et al.
Publicado: (2022)

A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
por: Xia, Fada, et al.
Publicado: (2021)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

Resistance to immune checkpoint inhibitors in gastric cancer
por: Liu, Kai, et al.
Publicado: (2023)

Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma
por: Zhang, Zeyu, et al.
Publicado: (2022)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential
por: Zhang, Wenqin, et al.
Publicado: (2022)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
por: Nie, Chuang, et al.
Publicado: (2022)

Role of an Exosomes-Related lncRNAs Signature in Tumor Immune Microenvironment of Gastric Cancer
por: Li, Chan, et al.
Publicado: (2022)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
por: Wang, Zicheng, et al.
Publicado: (2022)

Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer
por: Sun, Jie, et al.
Publicado: (2021)

A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma
por: Ye, Chen, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment
por: Ding, Dayong, et al.
Publicado: (2022)

Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
por: Zhou, Shuyi, et al.
Publicado: (2022)

Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response
por: Peng, Bi, et al.
Publicado: (2023)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
por: Chi, Hao, et al.
Publicado: (2022)

Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
por: Ma, Jingxin, et al.
Publicado: (2023)

Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction
por: Zhang, Chen, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
por: Zhang, Mengzhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_74hj6ms50i936bodh22lj06mq7